Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin H Preller

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|May 8, 2024
Psychedelics in Medicine: Can Evidence Keep Up With Enthusiasm?Harriet de Wit, Friederike Holze, Katrin H Preller
Current Topics in Behavioral Neurosciences|December 15, 2021
Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of ActionNathalie M Rieser, Marcus Herdener, Katrin H Preller
Journal of Neurochemistry|March 11, 2022
A neurobiological perspective on social influence: Serotonin and social adaptationPatricia Duerler, Franz X Vollenweider, Katrin H Preller
The European Journal of Neuroscience|November 19, 2024
New trends in the empirical study of consciousness: Measures and mechanismsAthina Tzovara, Thomas Andrillon, Katrin H Preller, et al.
Current Topics in Behavioral Neurosciences|July 30, 2024
Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse EffectsNathalie M Rieser, Timo T Schmidt, Katrin H Preller
Neuroscience and Biobehavioral Reviews|June 2, 2025
Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humansLucie Berkovitch, Baptiste Fauvel, Katrin H Preller, et al.
Biological Psychiatry|January 25, 2024
Neuroimaging Biomarkers for Drug Discovery and Development in SchizophreniaKatrin H Preller, Joachim Scholpp, Andreas Wunder, et al.
Frontiers in Pharmacology|August 8, 2022
Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectivesLeor Roseman, Katrin H Preller, Evgenia Fotiou, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 15, 2016
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experienceThomas Pokorny, Katrin H Preller, Rainer Kraehenmann, et al.
The International Journal of Neuropsychopharmacology|June 23, 2017
Effect of Psilocybin on Empathy and Moral Decision-MakingThomas Pokorny, Katrin H Preller, Michael Kometer, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|May 8, 2024
Psychedelics in Medicine: Can Evidence Keep Up With Enthusiasm?Harriet de Wit, Friederike Holze, Katrin H Preller
Current Topics in Behavioral Neurosciences|December 15, 2021
Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of ActionNathalie M Rieser, Marcus Herdener, Katrin H Preller
Journal of Neurochemistry|March 11, 2022
A neurobiological perspective on social influence: Serotonin and social adaptationPatricia Duerler, Franz X Vollenweider, Katrin H Preller
The European Journal of Neuroscience|November 19, 2024
New trends in the empirical study of consciousness: Measures and mechanismsAthina Tzovara, Thomas Andrillon, Katrin H Preller, et al.
Current Topics in Behavioral Neurosciences|July 30, 2024
Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse EffectsNathalie M Rieser, Timo T Schmidt, Katrin H Preller
Neuroscience and Biobehavioral Reviews|June 2, 2025
Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humansLucie Berkovitch, Baptiste Fauvel, Katrin H Preller, et al.
Biological Psychiatry|January 25, 2024
Neuroimaging Biomarkers for Drug Discovery and Development in SchizophreniaKatrin H Preller, Joachim Scholpp, Andreas Wunder, et al.
Frontiers in Pharmacology|August 8, 2022
Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectivesLeor Roseman, Katrin H Preller, Evgenia Fotiou, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 15, 2016
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experienceThomas Pokorny, Katrin H Preller, Rainer Kraehenmann, et al.
The International Journal of Neuropsychopharmacology|June 23, 2017
Effect of Psilocybin on Empathy and Moral Decision-MakingThomas Pokorny, Katrin H Preller, Michael Kometer, et al.
Pageof 11